Electroacupuncture for trigeminal neuralgia pain relief
Part of Brain & nervous system, Mouth & dental clinical trials.
This trial tests if adding electroacupuncture to your current medication can better control trigeminal neuralgia pain and reduce side effects. You should already be taking carbamazepine or oxcarbazepine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with trigeminal neuralgia (facial pain from a nerve) according to official guidelines.
- You are between 18 and 75 years old.
- You currently take carbamazepine (400-800 mg per day) or oxcarbazepine (800-1600 mg per day).
- You are awake, alert, and can describe your pain level.
- You do not have other serious medical conditions like epilepsy, heart/liver/kidney disease, or poorly controlled blood pressure or blood sugar.
- You are not pregnant or breastfeeding, and do not have a pacemaker.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding electroacupuncture (a type of acupuncture with mild electric current) helps reduce facial pain in people with trigeminal neuralgia. It may help if you are already on carbamazepine medicine but still have pain.
This trial tests whether adding pregabalin to your usual carbamazepine treatment can better control trigeminal neuralgia pain. It is for people with classic trigeminal neuralgia who want to see if a combination of medicines can help.
This trial tests two image-guided procedures to treat severe facial pain from trigeminal neuralgia. It compares using a CT scan versus an X-ray video to guide a needle that heats the nerve to stop pain signals.
This study compares two types of pulsed radiofrequency treatment for severe trigeminal neuralgia (a type of facial pain) that hasn't been helped enough by medication. The goal is to see which method works better and is safer for relieving pain.
This study measures nerve activity (electrical signals in nerves) in people who have trigeminal neuralgia and are getting a common facial pain procedure. It may help researchers better understand the condition and improve future treatments.
This trial tests a new drug called RP-008 combined with varenicline (a quit-smoking medication) to relieve severe facial pain from trigeminal neuralgia. If you've already tried standard pain medications without enough relief, this combination might help reduce your pain attacks.
Hear when a new Trigeminal Neuralgia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.